openPR Logo
Press release

PREMIER Biosoft International Releases version 4.50 of SimVector with Support for Loading Vector NTI® DNA Files

06-11-2009 03:01 PM CET | Science & Education

Press release from: PREMIER Biosoft International

PREMIER Biosoft International Releases version 4.50

Palo Alto, California – June 1, 2009- PREMIER Biosoft International today announced the world wide release of SimVector version 4.50. The new version includes support for loading Vector NTI® DNA (*.gb) files. Simply select File>Open>Sequence>From File and browse to the file location, no need to import or archive files. SimVector loads the sequence, reads the annotations and automatically scan all the analysis results performed in Vector NTI®.

The analysis information such as restriction analysis, ORF search and component fragment information is presented under separate tabs: features under the Feature tab, enzyme information under the Enzyme tab, ORF information under the ORF tab and component fragment information under the Note tab. This enables the data to be properly organized and in a format so that it is easily accessible.

“With this release, we are offering a cost effective but a powerful tool to all users who have their cloning research based on Vector NTI®.” said Kay Brown, V.P. Business Development and Marketing.

For details, please visit: http://www.premierbiosoft.com/plasmid_maps/VectorNTI.html

About PREMIER Biosoft International:
Founded in 1994, the company is a group of computer scientists and molecular biologists dedicated to producing cutting-edge intuitive software for the molecular biologist. The goal of the company is to study the most recent innovations in molecular biology and translate them into software products that aid biologists. Additional information about PREMIER Biosoft International is available at http://www.PremierBiosoft.com.

Contact:
Arun Apte
PREMIER Biosoft International
650-856-2703
http://www.PremierBiosoft.com

Founded in 1994, is a group of computer scientists and molecular biologists dedicated to producing cutting edge intuitive software for the molecular biologist. Our goal is to study the most recent innovations in molecular biology and translate them into software products that aid the biologist.

PREMIER Biosoft International
3786 Corina Way
Palo Alto CA 94303-4504
USA

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PREMIER Biosoft International Releases version 4.50 of SimVector with Support for Loading Vector NTI® DNA Files here

News-ID: 83370 • Views:

More Releases for Vector

Lentiviral Vector Manufacturing Market Size
According to a new market research report published by Global Market Estimates, the Global Lentiviral Vector Manufacturing Market is projected to grow at a CAGR value of 17.8% from 2022 and 2027. Charles River Laboratories, Vivebiotech, Thermo Fisher Scientific. Inc., GenScript, Creative Biogene, OriGene Technologies, Inc., Oxford Biomedica, Merck KGaA, Takara Bio, Pall Corporation, ITSBio Inc., ANDELYN BIOSCIENCES, Sino Biological Inc., Cellomics Technology, LLC, Virica Biotech, Cell Biolabs, Inc., SignaGen
Viral Vector Manufacturing Market - Forecasts to 2027
According to a new market research report published by Global Market Estimates, the Global Viral Vector Manufacturing Market is projected to grow at a CAGR value of 20.5% from 2022 to 2027. The rising number of cancer patients affected by increased alcohol intake and unhealthy lifestyles, as well as the burgeoning utilization of viral vectors in novel therapeutic delivery, along with their use as effective carriers of virus-disabling sequence data
Adeno-Associated Viral Vector Manufacturing Market
According to a new market research report published by Global Market Estimates, the Global Adeno-Associated Viral Vector Manufacturing Market is projected to grow at a CAGR value of 22.9% from 2022 and 2027. Biomarin Pharmaceutical, Sarepta Therapeutics, Roche (Spark Therapeutics), Sangamo, Pfizer, NightstaRx, Freeline Therapeutics, Horama S.A, MeiraGTx, RegenxBio, Asklepios Biopharmaceutical, and Audentes Therapeutics, among others, are the key players in the adeno-associated viral vector manufacturing market. Browse 151 Market Data
Global Viral Vector Manufacturing Market Demand 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Viral Vector Manufacturingindustry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Viral Vector Manufacturingand market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). GlobalInfoResearchoffers a latest published report on Viral Vector ManufacturingMarket Analysis and Forecast 2019-2025delivering key insights and providing a competitive advantage to
Global Viral Vector Development Service Market
The Viral Vector Development Service Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Owing to the immense potential of gene therapy, the use of viral vectors has increased significantly over the years. In order to fulfill the current need of viral vectors,
Isomaltitol Market 2017 - Beneo, Cargill, Mitsui Sugar, Vector
The Global Isomaltitol Market 2017 Industry Research Report focused on global and regional market, major manufacturers, as well as the current state of the Isomaltitol industry. First, "Global Isomaltitol Industry 2017" report analyzed the basic scope of this industry like definition, specification, classification, application, industry policy, news analysis and Isomaltitol industry chain structure. Major Companies Covered in this report:- Beneo Cargill Mitsui Sugar Vector Request For Report Sample @ https://goo.gl/oe1Tdh The analysis on Isomaltitol industry is provided